Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AUTL |
---|---|---|
09:32 ET | 24278 | 3.32 |
09:34 ET | 4021 | 3.2419 |
09:36 ET | 7089 | 3.26 |
09:38 ET | 4141 | 3.285 |
09:39 ET | 6843 | 3.285 |
09:41 ET | 100 | 3.28 |
09:43 ET | 700 | 3.28 |
09:45 ET | 2440 | 3.265 |
09:48 ET | 19030 | 3.245 |
09:50 ET | 4813 | 3.24 |
09:52 ET | 30593 | 3.275 |
09:54 ET | 10169 | 3.26 |
09:56 ET | 19338 | 3.215 |
09:57 ET | 41568 | 3.29 |
09:59 ET | 6656 | 3.29 |
10:01 ET | 22816 | 3.28 |
10:03 ET | 1687 | 3.285 |
10:06 ET | 9260 | 3.28 |
10:08 ET | 2185 | 3.26 |
10:10 ET | 1500 | 3.265 |
10:12 ET | 6582 | 3.245 |
10:14 ET | 12007 | 3.235 |
10:15 ET | 5414 | 3.255 |
10:17 ET | 2925 | 3.245 |
10:19 ET | 3741 | 3.235 |
10:21 ET | 4410 | 3.225 |
10:24 ET | 7245 | 3.235 |
10:26 ET | 19037 | 3.2 |
10:28 ET | 20635 | 3.2 |
10:30 ET | 4677 | 3.19 |
10:32 ET | 5339 | 3.1799 |
10:33 ET | 10536 | 3.17 |
10:35 ET | 4968 | 3.1601 |
10:37 ET | 3520 | 3.135 |
10:39 ET | 23911 | 3.145 |
10:42 ET | 3980 | 3.135 |
10:44 ET | 2508 | 3.155 |
10:46 ET | 14416 | 3.165 |
10:48 ET | 4379 | 3.165 |
10:50 ET | 23766 | 3.205 |
10:51 ET | 6048 | 3.205 |
10:53 ET | 12951 | 3.215 |
10:55 ET | 41075 | 3.225 |
10:57 ET | 4653 | 3.235 |
11:00 ET | 300 | 3.235 |
11:02 ET | 3989 | 3.24 |
11:04 ET | 4013 | 3.22 |
11:06 ET | 5273 | 3.215 |
11:08 ET | 581 | 3.21 |
11:09 ET | 3048 | 3.215 |
11:11 ET | 1797 | 3.205 |
11:13 ET | 15165 | 3.225 |
11:15 ET | 3038 | 3.235 |
11:18 ET | 2448 | 3.23 |
11:20 ET | 3599 | 3.23 |
11:22 ET | 3975 | 3.235 |
11:24 ET | 3709 | 3.235 |
11:26 ET | 1438 | 3.23 |
11:27 ET | 2429 | 3.225 |
11:29 ET | 3538 | 3.235 |
11:31 ET | 4291 | 3.235 |
11:33 ET | 200 | 3.235 |
11:36 ET | 467 | 3.23 |
11:38 ET | 4971 | 3.22 |
11:40 ET | 3683 | 3.235 |
11:42 ET | 4646 | 3.22 |
11:44 ET | 1923 | 3.215 |
11:45 ET | 6598 | 3.225 |
11:47 ET | 7997 | 3.235 |
11:49 ET | 4372 | 3.22 |
11:51 ET | 1429 | 3.215 |
11:54 ET | 684 | 3.215 |
11:56 ET | 9161 | 3.235 |
11:58 ET | 6247 | 3.26 |
12:00 ET | 2722 | 3.265 |
12:02 ET | 23897 | 3.315 |
12:03 ET | 1152 | 3.315 |
12:05 ET | 1169 | 3.315 |
12:07 ET | 300 | 3.315 |
12:09 ET | 13107 | 3.325 |
12:12 ET | 11721 | 3.34 |
12:14 ET | 3692 | 3.325 |
12:16 ET | 9329 | 3.325 |
12:18 ET | 10781 | 3.325 |
12:20 ET | 3300 | 3.33 |
12:21 ET | 1600 | 3.33 |
12:23 ET | 3873 | 3.33 |
12:25 ET | 25758 | 3.335 |
12:27 ET | 14145 | 3.335 |
12:30 ET | 9108 | 3.335 |
12:32 ET | 7143 | 3.325 |
12:34 ET | 3004 | 3.335 |
12:36 ET | 6120 | 3.33 |
12:38 ET | 16698 | 3.325 |
12:39 ET | 206757 | 3.345 |
12:41 ET | 18651 | 3.335 |
12:43 ET | 600 | 3.335 |
12:48 ET | 2788 | 3.335 |
12:50 ET | 547 | 3.335 |
12:52 ET | 21258 | 3.37 |
12:54 ET | 14038 | 3.41 |
12:56 ET | 5784 | 3.39 |
12:57 ET | 8016 | 3.39 |
12:59 ET | 402 | 3.39 |
01:01 ET | 200 | 3.395 |
01:03 ET | 1501 | 3.385 |
01:06 ET | 2200 | 3.385 |
01:08 ET | 3062 | 3.4 |
01:10 ET | 200 | 3.395 |
01:12 ET | 400 | 3.395 |
01:14 ET | 200 | 3.395 |
01:15 ET | 1400 | 3.395 |
01:17 ET | 751 | 3.395 |
01:19 ET | 5850 | 3.42 |
01:21 ET | 2864 | 3.41 |
01:24 ET | 4342 | 3.39 |
01:26 ET | 1834 | 3.375 |
01:28 ET | 3383 | 3.37 |
01:30 ET | 2160 | 3.37 |
01:32 ET | 5264 | 3.37 |
01:33 ET | 3200 | 3.365 |
01:35 ET | 2145 | 3.365 |
01:37 ET | 1100 | 3.365 |
01:39 ET | 9295 | 3.345 |
01:42 ET | 800 | 3.345 |
01:44 ET | 1000 | 3.345 |
01:46 ET | 900 | 3.345 |
01:48 ET | 1400 | 3.345 |
01:50 ET | 3000 | 3.35 |
01:51 ET | 7487 | 3.345 |
01:53 ET | 1500 | 3.345 |
01:55 ET | 2538 | 3.345 |
01:57 ET | 1514 | 3.345 |
02:00 ET | 900 | 3.345 |
02:02 ET | 1027 | 3.345 |
02:04 ET | 1658 | 3.345 |
02:06 ET | 1700 | 3.345 |
02:08 ET | 12180 | 3.37 |
02:09 ET | 3761 | 3.37 |
02:11 ET | 5560 | 3.37 |
02:13 ET | 3772 | 3.395 |
02:15 ET | 1736 | 3.41 |
02:18 ET | 12645 | 3.415 |
02:20 ET | 40186 | 3.435 |
02:22 ET | 2798 | 3.45 |
02:24 ET | 15242 | 3.45 |
02:26 ET | 29954 | 3.47 |
02:27 ET | 5681 | 3.465 |
02:29 ET | 5412 | 3.46 |
02:31 ET | 3000 | 3.46 |
02:33 ET | 8397 | 3.455 |
02:36 ET | 4118 | 3.46 |
02:38 ET | 8470 | 3.47 |
02:40 ET | 8878 | 3.485 |
02:42 ET | 7043 | 3.485 |
02:44 ET | 4418 | 3.49 |
02:45 ET | 7744 | 3.49 |
02:47 ET | 3197 | 3.495 |
02:49 ET | 15941 | 3.495 |
02:51 ET | 19612 | 3.475 |
02:54 ET | 11228 | 3.5 |
02:56 ET | 10412 | 3.49 |
02:58 ET | 9240 | 3.49 |
03:00 ET | 4073 | 3.49 |
03:02 ET | 8116 | 3.475 |
03:03 ET | 28228 | 3.465 |
03:05 ET | 3279 | 3.47 |
03:07 ET | 8973 | 3.485 |
03:09 ET | 8012 | 3.49 |
03:12 ET | 13932 | 3.495 |
03:14 ET | 8613 | 3.5 |
03:16 ET | 38171 | 3.48 |
03:18 ET | 10749 | 3.485 |
03:20 ET | 7348 | 3.485 |
03:21 ET | 10071 | 3.5 |
03:23 ET | 6363 | 3.495 |
03:25 ET | 15577 | 3.495 |
03:27 ET | 27670 | 3.495 |
03:30 ET | 13111 | 3.485 |
03:32 ET | 34974 | 3.495 |
03:34 ET | 12121 | 3.485 |
03:36 ET | 163408 | 3.55 |
03:38 ET | 32250 | 3.485 |
03:39 ET | 19091 | 3.495 |
03:41 ET | 8820 | 3.5 |
03:43 ET | 8927 | 3.495 |
03:45 ET | 18997 | 3.495 |
03:48 ET | 1633 | 3.495 |
03:50 ET | 5138 | 3.5 |
03:52 ET | 165393 | 3.495 |
03:54 ET | 17880 | 3.495 |
03:56 ET | 26776 | 3.495 |
03:57 ET | 17998 | 3.485 |
03:59 ET | 36651 | 3.48 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Autolus Therapeutics PLC | 893.9M | -2.9x | --- |
Cassava Sciences Inc | 890.4M | -10.6x | --- |
Rapport Therapeutics Inc | 850.8M | -16.0x | --- |
Cullinan Therapeutics Inc | 951.0M | -5.5x | --- |
Tyra Biosciences Inc | 830.1M | -9.5x | --- |
Longboard Pharmaceuticals Inc | 803.3M | -12.0x | --- |
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $925.8M |
---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.10 |
EPS | $-1.21 |
Book Value | --- |
P/E Ratio | -2.9x |
Price/Sales (TTM) | 88.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,670.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.